Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-05-25 @ 5:57 PM
Study NCT ID:
NCT06067568
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2023-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese Participants
Sponsor:
AbbVie
Organization: